Table 2.
Pilot study compliance and 12-month primary and secondary outcomes
| Treatment (n = 65) | Control (n = 56) | Odds ratio | (95% CI) | |||
|---|---|---|---|---|---|---|
| Study compliance | ||||||
| Completed >3 sessions, % (n) | 66.2 | (43) | 62.5 | (35) | ||
| Completed 6-month survey, % (n) | 60.0 | (39) | 53.6 | (30) | ||
| Completed 12-month survey, % (n) | 92.3 | (60) | 85.7 | (48) | ||
| Primary outcome: utilizationa | ||||||
| >1 ED visit/hospitalization in follow-up year, % (n) | 33.8 | (22) | 46.4 | (26) | 0.53 | (0.24–1.15) |
| Secondary outcomes | ||||||
| Change of ACT score from baseline, median (range) | 2 | (24) | 2 | (20) | ||
| Functional statusb in the last 30 days | ||||||
| >2 symptom days/week over 30 days | ||||||
| Yes, % (n) | 25.9 | (15) | 28.3 | (13) | 0.87 | (0.36–2.11) |
| No, % (n) | 74.1 | (43) | 71.7 | (33) | ||
| >2 school days missed/30 days (any reason) | ||||||
| Yes, % (n) | 9.6 | (5) | 5.3 | (2) | 1.85 | (0.33–10.34) |
| No, % (n) | 90.4 | (47) | 94.7 | (36) | ||
| >2 school or work days missed/30 days (asthma) | ||||||
| Yes, % (n) | 9.5 | (4) | 0 | (0) | Not calculated | |
| No, % (n) | 90.5 | (38) | 100 | (29) | ||
| ASRDI at 12 months, mean (sd) | 3.1 | (1.2) | 2.7 | (1.2) | ||
| Targeted behaviors, % (n) | ||||||
| Among patients reporting controller medication at session 1 | ||||||
| Adherent >5 days of the past 7 days, % (n) | 62.1 | (18) | 50 | (5) | 1.62 | (0.38–6.93) |
| Among patients reporting rescue inhaler at session 1 | ||||||
| Rescue inhaler available >5 days/7 days, % (n) | 54.5 | (24) | 70.4 | (19) | 0.50 | (0.18–1.36) |